No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
L240816P80000
- 1.90
- +0.70+58.33%
15min DelayClose Jul 19 16:00 ET
1.90High1.90Low
1.90Open1.20Pre Close4 Volume16 Open Interest80.00Strike Price760.00Turnover0.00%IV-0.05%PremiumAug 16, 2024Expiry Date1.94Intrinsic Value100Multiplier25DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma43.98Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
News
Express News | Loews Corp Shares Hit Record High, Last up 1.3%
Loews (NYSE:L) Shareholders Have Earned a 7.6% CAGR Over the Last Five Years
Citi Research's AI Hedge Stocks - Part I
Loews Corporation to Release Second Quarter 2024 Results on July 29, 2024
Loews Corporation (NYSE: L) will report second quarter 2024 financial results on Monday, July 29, 2024. On that date the Company will also post...
Should Weakness in Loews Corporation's (NYSE:L) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
With its stock down 2.9% over the past three months, it is easy to disregard Loews (NYSE:L). However, stock prices are usually driven by a company's financials over the long term, which in this case
Hesen Biotech acquires 14 branded pharmaceuticals from Celltrion, enriching product pipeline in 8 countries.
On June 28th, Heisen Biotech Co., Ltd. (Heisen Biotech) announced that it has officially completed the acquisition of the commercial rights of 14 branded products under the South Korean biopharmaceutical company Celltrion in multiple countries and regions in the Asia-Pacific region, and holds the marketing authorization holder (MAH) rights for these products in eight countries and regions including South Korea (excluding Nexinavir, Yidabio and Aiketuo), Singapore, Thailand, Australia, and Hong Kong, China. It is reported that this acquisition will enrich the company's product pipeline in eight countries and regions outside of mainland China and establish a more complete international supply chain and quality system.
Comments
Despite a lower ROE compared to the industry average, Loews' significant net income growth and high rate of profit retention are positive aspects of its business. These factors could be contributing to the company's stock price increase.
1
The recent insider selling of Loews shares, despite high insider ownership, raises caution. The longer-term picture of more insider selling than buying over the past year also does not provide much comfort.
Last week, the new retail sales data came in higher than estimate. This shows that last month’s holiday shopping was more than expected.
A continuous strong consumer spending could potentially fuel inflation again.
I don’t think the Fed will be so eager to cut rates soon
$Walmart(WMT.US$ $Target(TGT.US$ $Coca-Cola(KO.US$ $PepsiCo(PEP.US$ $Lululemon Athletica(LULU.US$ $USD(USDindex.FX$ $Home Depot(HD.US$ $Loews(L.US$ $iShares Russell 2000 ETF(IWM.US$ $Russell 3000 Index Ishares(IWV.US$ $Russell Midcap Index Ishares(IWR.US$ $Nike(NKE.US$ $Grab Holdings(GRAB.US$
A continuous strong consumer spending could potentially fuel inflation again.
I don’t think the Fed will be so eager to cut rates soon
$Walmart(WMT.US$ $Target(TGT.US$ $Coca-Cola(KO.US$ $PepsiCo(PEP.US$ $Lululemon Athletica(LULU.US$ $USD(USDindex.FX$ $Home Depot(HD.US$ $Loews(L.US$ $iShares Russell 2000 ETF(IWM.US$ $Russell 3000 Index Ishares(IWV.US$ $Russell Midcap Index Ishares(IWR.US$ $Nike(NKE.US$ $Grab Holdings(GRAB.US$
6
1
Read more